Merck & (MRK) Revenue — Quarter Ended Sep 30, 2025
Revenue for the quarter increased compared with the prior quarter and also rose relative to the same quarter a year earlier. The sequential gain was larger than the year-over-year increase.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the quarter increased compared with the prior quarter and also rose relative to the same quarter a year earlier. The sequential gain was larger than the year-over-year increase.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$17.3B
Revenue reported for this quarter.
Quarter-over-quarter
+9.3%
Change from the immediately preceding quarter.
Year-over-year
+3.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$64.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $15.6B | +6.8% |
| Mar 31, 2025 | $15.5B | -1.6% |
| Jun 30, 2025 | $15.8B | -1.9% |
| Sep 30, 2025 | $17.3B | +3.7% |
Revenue performance
The reported revenue moved higher, reflecting a positive direction for the quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue improved. Versus the same quarter one year earlier, revenue also increased, though at a more moderate pace.
What to watch
Cash provided by operating activities for the first nine months declined compared with the same period a year earlier.